Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

叙述的 医学 疾病 噪音(视频) 重症监护医学 心理学 内科学 计算机科学 艺术 文学类 人工智能 图像(数学)
作者
Michael Schöll,Agathe Vrillon,Takeshi Ikeuchi,Frances C. Quevenco,Leonardo Iaccarino,S. Vasileva-Metodiev,Samantha Burnham,James A. Hendrix,Stéphane Epelbaum,Henrik Zetterberg,Sebastian Palmqvist
出处
期刊:JPAD [Springer Science+Business Media]
卷期号:: 100056-100056
标识
DOI:10.1016/j.tjpad.2024.100056
摘要

As novel, anti-amyloid therapies have become more widely available, access to timely and accurate diagnosis has become integral to ensuring optimal treatment of patients with early-stage Alzheimer's disease (AD). Plasma biomarkers are a promising tool for identifying AD pathology; however, several technical and clinical factors need to be considered prior to their implementation in routine clinical use. Given the rapid pace of advancements in the field and the wide array of available biomarkers and tests, this review aims to summarize these considerations, evaluate available platforms, and discuss the steps needed to bring plasma biomarker testing to the clinic. We focus on plasma phosphorylated(p)-tau, specifically plasma p-tau217, as a robust candidate across both primary and secondary care settings. Despite the high performance and robustness demonstrated in research, plasma p-tau217, like all plasma biomarkers, can be affected by analytical and pre-analytical variability as well as patient comorbidities, sex, ethnicity, and race. This review also discusses the advantages of the two-point cut-off approach to mitigating these factors, and the challenges raised by the resulting intermediate range measurements, where clinical guidance is still unclear. Further validation of plasma p-tau217 in heterogeneous, real-world cohorts will help to increase confidence in testing and support establishing a standardized approach. Plasma biomarkers are poised to become a more affordable and less invasive alternative to PET and CSF testing. However, understanding the factors that impact plasma biomarker measurement and interpretation is critical prior to their implementation in routine clinical use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
KX2024完成签到,获得积分10
1秒前
松松发布了新的文献求助20
4秒前
nusiew完成签到,获得积分10
4秒前
huiluowork完成签到 ,获得积分10
5秒前
陶醉的翠霜完成签到 ,获得积分10
5秒前
5秒前
冷静如松完成签到 ,获得积分10
12秒前
14秒前
浮云完成签到 ,获得积分10
15秒前
屈岂愈完成签到,获得积分10
16秒前
30秒前
Pupil完成签到,获得积分10
30秒前
偏偏意气用事完成签到,获得积分10
31秒前
安安完成签到,获得积分10
35秒前
cttc完成签到,获得积分10
36秒前
Chnimike完成签到 ,获得积分10
36秒前
40秒前
红茸茸羊完成签到 ,获得积分10
40秒前
年轻千愁完成签到 ,获得积分10
42秒前
liu完成签到,获得积分10
43秒前
量子星尘发布了新的文献求助10
43秒前
Wanyeweiyu完成签到,获得积分10
45秒前
Fury完成签到 ,获得积分10
50秒前
风中幻梦完成签到,获得积分10
52秒前
bigpluto完成签到,获得积分10
53秒前
55秒前
是谁还没睡完成签到 ,获得积分10
56秒前
盘尼西林发布了新的文献求助10
1分钟前
zzz完成签到 ,获得积分10
1分钟前
dktrrrr完成签到,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
丘比特应助科研通管家采纳,获得20
1分钟前
1分钟前
ccc完成签到,获得积分10
1分钟前
萧秋灵完成签到,获得积分10
1分钟前
缓慢冥幽完成签到,获得积分10
1分钟前
旺仔同学完成签到,获得积分10
1分钟前
吉以寒完成签到,获得积分10
1分钟前
科研老兵完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022